Search Results - "Santana, Clemence"

Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies by Bussot, Lucile, Chevalier, Simon, Cristante, Justine, Grange, Béatrice, Tesson, Bruno, Deteix‐Santana, Clémence, Orsini‐Piocelle, Frédérique, Leyronnas, Cécile, Dupire, Sophie, Gressin, Rémy, Salles, Gilles, Bachy, Emmanuel, Emadali, Anouk, Valmary‐Degano, Séverine, Huet, Sarah, Lefebvre, Christine, Carras, Sylvain

“…Summary Follicular lymphomas (FLs) with MYC rearrangements (MYC‐R) and extra copies of MYC (MYC‐EC) are rare and the prognosis impact is uncertain. We…”
Get full text

Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM) by Jouzier, Claire, Cherait, Amina, Cony‐Makhoul, Pascale, Hamel, Jean‐François, Veloso, Melanie, Thepot, Sylvain, Cluzeau, Thomas, Stamatoullas, Aspasia, Garnier, Alice, Guerci‐Bresler, Agnès, Dimicoli‐Salazar, Sophie, Pica, Gian Matteo, Cheze, Stéphane, Santana, Clémence, Chermat, Fatiha, Fenaux, Pierre, Park, Sophie

“…Background MDS‐RS patients are characterized by chronic anemia and a low risk of Acute Myeloid Leukemia (AML) progression and they generally become Red Blood…”
Get full text

Clinical outcome of therapy‐related acute myeloid leukemia patients. Real‐life experience in a University Hospital and a Cancer Center in France by Belhabri, Amine, Heiblig, Mael, Morisset, Stephane, Vila, Liliana, Santana, Clémence, Nicolas‐Virelizier, Emmanuelle, Hayette, Sandrine, Tigaud, Isabelle, Plesa, Adriana, Labussiere‐Wallet, Hélène, Sobh, Mohamad, Michallet, Anne‐Sophie, Marie, Balsat, Nicolini, Franck‐Emmanuel, Guillermin, Yann, Gaëlle, Fossard, Lebras, Laure, Rey, Philippe, Jauffret‐Bertholon, Lucie, Laude, Marie‐Charlotte, Sandrine, Loron, Michallet, Mauricette

“…Background t‐AML occurs after a primary malignancy treatment and retains a poor prognosis. Aims To determine the impact of primary malignancies, therapeutic…”
Get full text

Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial by Fournier, Baptiste, Nicolas-Virelizier, Emmanuelle, Russo, Chiara, Pérol, Olivia, Millet, Guillaume Y, Maire, Aurélia, Delrieu, Lidia, Michallet, Anne-Sophie, Assaad, Souad, Belhabri, Amine, Gilis, Lila, Guillermin, Yann, Lebras, Laure, Rey, Philippe, Santana, Clémence, Pretet-Flamand, Emilie, Terret, Catherine, Michallet, Mauricette, Fervers, Béatrice

“…IntroductionOlder adults with cancer suffer from the combined effects of ageing, cancer disease and treatment side effects. The main treatment for patients…”
Get full text

Venetoclax Pharmacokinetics in Real World AML Patients: A Real Candidate for Therapeutic Drug Monitoring by Philippe, Michael, Guitton, Jerome, Favier, Bertrand, Santana, Clemence, Nicolas-Virelizier, Emmanuelle, Guillermin, Yann, Michallet, Anne-Sophie, Michallet, Mauricette, Belhabri, Amine

Get full text

Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry by Comont, Thibault, D'Aveni, Maud, Schenone, Laurence, Torregrosa-Díaz, Jose Miguel, Aguinaga, Lorea, Pardo, Juan, Sebert, Marie, Visanica, Sorin, Santana, Clemence, Le Clech, Lenaig, Stamatoullas, Aspasia, Thepot, Sylvain, Daguindau, Etienne, Beziat, Guillaume, Botin, Teresa, Dimicoli, Sophie, Park, Sophie, Paubelle, Etienne, Slama, Bohrane, Willems, Lise, Debarri, Houria, Gyan, Emmanuel, Calmettes, Claire, Rauzy, Odile, Chermat, Fatiha, Fontenay, Michaela, Ades, Lionel, Fenaux, Pierre

“…Background EMA has recently approved Luspatercept (LUSPA) for the treatment of anemia in adult patients with RBC transfusion-dependent (TD) very low- to…”
Get full text

Long-Term Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib Front-Line by Nicolini, Franck E, Alcazer, Vincent, Cony-Makhoul, Pascale, Dulucq, Stephanie, Hayette, Sandrine, Morisset, Stephane, Cayuela, Jean-Michel, Fort, Marie-Pierre, Bouvier, Christophe, Deteix-Santana, Clemence, Lengline, Etienne, Rea, Delphine, Mahon, Francois-Xavier, Etienne, Gabriel

“…▪ Nilotinib (NIL) 600 mg daily has demonstrated its superiority over Imatinib 400 mg daily in terms of response and incidence of deep molecular response in the…”
Get full text

Therapy-Related Acute Myeloid Leukemia (t-AML) and the Advantage of Intensive Chemotherapy: Real-Life Analysis from Two Regional French Centers by Belhabri, Amine, Heiblig, Mael, Morisset, Stephane, Vila, Liliana, Hayette, Sandrine, Santana, Clemence, Labussière, Hélène, Tigaud, Isabelle, Plesa, Adriana, Michallet, Anne-Sophie, Nicolas-Virelizier, Emmanuelle, Nicolini, Franck E., Gilis, Lila, Rey, Philippe, Balsat, Marie, Quintela, Adrien, Ducastelle, Sophie, Assad, Souad, Larcher, Marie, Fossard, Gaelle, Thomas, Xavier, Sobh, Mohamad, Michallet, Mauricette

“…Rational: Patients with t-AML are those previously treated for primary malignancy and are categorized with poor prognosis. t-AML treatment options include…”
Get full text

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study by Comont, Thibault, Meunier, Mathieu, Cherait, Amina, Santana, Clemence, Cluzeau, Thomas, Slama, Bohrane, Laribi, Kamel, Giraud, Jean‐Thomas, Dimicoli, Sophie, Berceanu, Ana, Le Clech, Lenaïg, Cony‐Makhoul, Pascale, Gruson, Berangere, Torregrosa, Jose, Sanhes, Laurence, Jachiet, Vincent, Azerad, Marie‐Agnes, Al Jijakli, Ahmad, Gyan, Emmanuel, Gaudin, Clement, Broner, Jonathan, Guerveno, Claire, Guillaume, Thierry, Ades, Pr Lionel, Beyne‐Rauzy, Odile, Fenaux, Pierre

“…Summary Despite a moderate prevalence in low‐risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML), thrombocytopenia remains a risk…”
Get full text

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group by Gross, Zofia, Tauveron-Jalenques, Urbain, Aspas Requena, Gaspar, Carre, Martin, Meunier, Mathieu, Tavernier, Emmanuelle, Cornillon, Jérôme, Belhabri, Amine, Michallet, Mauricette, Contejean, Adrien, Mauz, Natacha, Nadine, Boullanger FOW HENG, Antal, Daciana Claudia, Pica, Gian Matteo, Arthur, Dony, Santana, Clémence, Rocher, Clement, Heiblig, Mael

“…Azacytidine and venetoclax combination regimen (AZA/VEN) is the standard of care in frontline acute myeloid leukemia (AML) settings for unfit to intensive…”
Get full text

POSTER: AML-454 Real-World Use of Azacitidine (AZA) and Venetoclax (VEN) in Acute Myeloid Leukemia (AML) in Frontline and Relapse/Refractory (R/R) Settings: Multicenter Study From French AURAML Group by Heiblig, Maël, Tavernier, Emmanuelle, Requena, Gaspar Aspas, Belhabri, Amine, Mauz, Natacha, Contejean, Adrien, Pica, Gian-Matteo, Carré, Martin, Rocher, Clément, Santana, Clémence, Gross, Zofia

Get full text

AML-454 Real-World Use of Azacitidine (AZA) and Venetoclax (VEN) in Acute Myeloid Leukemia (AML) in Frontline and Relapse/Refractory (R/R) Settings: Multicenter Study From French AURAML Group by Heiblig, Maël, Tavernier, Emmanuelle, Requena, Gaspar Aspas, Belhabri, Amine, Mauz, Natacha, Contejean, Adrien, Pica, Gian-Matteo, Carré, Martin, Rocher, Clément, Santana, Clémence, Gross, Zofia

“…Azacytidine and venetoclax combination regimen (AZA/VEN) is the standard of care in AML settings for unfit to intensive chemotherapy patients. However, AZA/VEN…”
Get full text

Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM) by Jouzier, Claire, Cherait, Amina, Cony-Makhoul, Pascale, Thepot, Sylvain, Cluzeau, Thomas, Stamatoulas Bastard, Aspasia, Peterlin, Pierre, Guerci Bresler, Agnes, Dimicoli-Salazar, Sophie, Pica, Gian-Matteo, Cheze, Stephane, Santana, Clémence, Chermat, Fatiha, Fenaux, Pierre, Park, Sophie

“…Background: MDS-RS are associated with a low risk of Acute Myeloid Leukemia (AML) progression and prolonged survival in most cases, but recurring anemia whose…”
Get full text

Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients by Belhabri, Amine, Vila, Liliana, Heiblig, Mael, Morisset, Stephane, Nicolas-Virelizier, Emmanuelle, Santana, Clémence, Tigaud, Isabelle, Hayette, Sandrine, Michallet, Anne-Sophie, Rey, Philippe, Guillermin, Yann, Assad, Souad, Lebras, Laure, Michallet, Mauricette

“…Background:Therapy related acute myeloid leukemia (t-AML) is a late complication following cytotoxic therapy for a primary neoplasm or a non-neoplastic…”
Get full text